| The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo P Ren, G Zou, B Bailly, S Xu, M Zeng, X Chen, L Shen, Y Zhang, P Guillon, ... Emerging microbes & infections 3 (1), 1-9, 2014 | 57 | 2014 |
| Multidisciplinary approaches identify compounds that bind to human ACE2 or SARS-CoV-2 spike protein as candidates to block SARS-CoV-2–ACE2 receptor interactions CJ Day, B Bailly, P Guillon, L Dirr, FEC Jen, BL Spillings, J Mak, ... MBio 12 (2), 10.1128/mbio. 03681-20, 2021 | 55 | 2021 |
| Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication B Bailly, CA Richard, G Sharma, L Wang, L Johansen, J Cao, ... Scientific reports 6 (1), 25806, 2016 | 55 | 2016 |
| Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin–neuraminidase inhibitors P Guillon, L Dirr, IM El-Deeb, M Winger, B Bailly, T Haselhorst, JC Dyason, ... Nature communications 5 (1), 5268, 2014 | 42 | 2014 |
| New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase VP Chibanga, L Dirr, P Guillon, IM El-Deeb, B Bailly, RJ Thomson, ... Antiviral Research 167, 89-97, 2019 | 28 | 2019 |
| Efficient blocking of enterovirus 71 infection by heparan sulfate analogues acting as decoy receptors DF Earley, B Bailly, A Maggioni, AR Kundur, RJ Thomson, CW Chang, ... ACS infectious diseases 5 (10), 1708-1717, 2019 | 23 | 2019 |
| A dual drug regimen synergistically blocks human parainfluenza virus infection B Bailly, L Dirr, IM El-Deeb, R Altmeyer, P Guillon, M von Itzstein Scientific reports 6 (1), 24138, 2016 | 19 | 2016 |
| A portable device for LAMP based detection of SARS-CoV-2 KR Sreejith, M Umer, L Dirr, B Bailly, P Guillon, M von Itzstein, N Soda, ... Micromachines 12 (10), 1151, 2021 | 17 | 2021 |
| Platinum complexes act as shielding agents against virus infection B Bailly, AK Gorle, L Dirr, AK Malde, NP Farrell, SJ Berners-Price, ... Chemical Communications 57 (38), 4666-4669, 2021 | 16 | 2021 |
| A sulfonozanamivir analogue has potent anti‐influenza virus activity Á Hadházi, L Li, B Bailly, A Maggioni, G Martin, L Dirr, JC Dyason, ... ChemMedChem 13 (8), 785-789, 2018 | 14 | 2018 |
| A sialosyl sulfonate as a potent inhibitor of influenza virus replication Á Hadházi, M Pascolutti, B Bailly, JC Dyason, A Borbás, RJ Thomson, ... Organic & Biomolecular Chemistry 15 (25), 5249-5253, 2017 | 13 | 2017 |
| Antiviral strategies against human metapneumovirus: Targeting the fusion protein A Van Den Bergh, B Bailly, P Guillon, M von Itzstein, L Dirr Antiviral Research 207, 105405, 2022 | 6 | 2022 |
| Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super‐infection M Zaman, VC Huber, DL Heiden, KN DeHaan, S Chandra, D Erickson, ... Clinical & Translational Immunology 10 (9), e1337, 2021 | 5 | 2021 |
| Enhanced tissue damage following H1N1 infection in human Precision-Cut Lung Slices (PCLS) O Danov, G Martin, A Greif, B Bailly, P Braubach, DD Jonigk, G Warnecke, ... C107. GOING VIRAL TO REPAIR, A5742-A5742, 2019 | 2 | 2019 |
| Novel insights into the host cell glycan binding profile of human metapneumovirus A Van Den Bergh, B Bailly, P Guillon, M von Itzstein, L Dirr Journal of Virology, e01641-23, 2024 | | 2024 |
| Drug repurposing for therapeutic discovery against human metapneumovirus infection A Van Den Bergh, P Guillon, M von Itzstein, B Bailly, L Dirr Antimicrobial Agents and Chemotherapy 66 (10), e01008-22, 2022 | | 2022 |
| A Portable Device for LAMP Based Detection of SARS-CoV-2. Micromachines 2021, 12, 1151 KR Sreejith, M Umer, L Dirr, B Bailly, P Guillon, M von Itzstein, N Soda, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| A human respiratory syncytial virus inhibitor and its target for antiviral drug design R Altmeyer, B Bailly, G Zou CN Patent CN105,232,562 B, 2016 | | 2016 |
| La protéine M2-1 du Virus Respiratoire Syncytial, une nouvelle cible potentiel pour des antiviraux CA Richard, B Bailly, R Altmeyer, JN Barr, JF Eleouet XVIIièmes Journées Francophones de Virologie 19 (2), 108, 2015 | | 2015 |
| An investigation into novel drug candidates against paediatric viral pathogens B Bailly Institute for Glycomics, Griffith University, 2015 | | 2015 |
Patrice GuillonInstitute for Glycomics - Griffith UniversityE-mailová adresa ověřena na: griffith.edu.au
